Our research suggests the multiplication of protein aggregates in individual regions of the brain, rather than their spread between regions, is key to the progression of Alzheimer’s disease.
Arts-related activities for people living with Alzheimer’s and other related disorders could improve people’s quality of life, but collaborating in communities requires a common language.
FDA approval of aducanumab (Aduhelm) was contentious. Its submission to Health Canada for approval highlights concerns about evidence, independence and transparency in Canada’s drug approval process.
Alzheimer’s disease is often associated with a decline in episodic memory. Patients will complain that they can’t remember events they’ve experienced, conversations they’ve had, things they’ve done.
Using a technique called admixture mapping, researchers can leverage the diversity of people with mixed ancestry to look for hard-to-find genetic risk factors for diseases like Alzheimer’s disease.
The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
‘Dementia friendly’ communities seek to support people with memory loss, recognize them as equals, celebrate their contributions and enable them to live with purpose in welcoming communities.
Adaptable neurons are tied to learning and memory but also to neurological disorders. By studying fruit flies, researchers found a mechanism that controls neuroplasticity.
It was first officially described 115 years ago, but we still do not have a cure for Alzheimer’s disease. The human brain is extremely complex, and Alzheimer’s is its most complex disease.